Facilitates high-speed, scalable, and cost-effective data transfer PLANO, Texas, Dec. 11, 2024 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), which…
December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival (OS) among patients with HR+, HER2- advanced breast…
PALM BEACH, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Due to the high computational…
December 09, 2024 12:00 ET | Source: Disc Medicine Inc Positive updates across all programs, including updates from ongoing clinical…
Poster presentation at ASH on Monday, December 9 at 6:00 p.m. PT / 9:00 p.m. ET CAMBRIDGE, Mass., Dec. 09,…
December 09, 2024 12:00 ET | Source: CRISPR Therapeutics AG -Preliminary data demonstrate that CTX112™ has the potential to provide…
Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs (74.1% vs. 52%) and vs. imatinib alone (76.2%…
December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest…
New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies…
December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics,…